Actively Recruiting
Effect of Hypoxia on FMISO PET to Response to Lu-177 PSMA Treatment
Led by Cigdem Soydal · Updated on 2024-05-29
30
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
It is aimed to evaluate hypoxia before Lu-177 PSMA treatment in prostate cancer and to show its effect on treatment success with 18F-FMISO PET imaging, which allows in-vivo evaluation and quantification of tumor hypoxia, which is known to be one of the factors affecting radiotherapy resistance.
CONDITIONS
Official Title
Effect of Hypoxia on FMISO PET to Response to Lu-177 PSMA Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- over 18 years old
- Patients diagnosed with prostate cancer who were referred to our clinic for Lu-177 PSMA treatment and were found suitable for treatment
You will not qualify if you...
- Has a life expectancy of less than 3 months
- ECOG>2
- contraindication for radionuclide treatment with Lu-177 PSMA
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ankara University Medical School
Ankara, Turkey (Türkiye), 06580
Actively Recruiting
Research Team
C
Cigdem Soydal, Asc Prof
CONTACT
E
Ecenur Dursun, Res Ass
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here